Cytokines in the colon, central nervous system and serum of irritable bowel syndrome rats

[1]  Yen‐Po Wang,et al.  Targeting the gut microbiota for the treatment of irritable bowel syndrome , 2019, Kaohsiung Journal of Medical Sciences.

[2]  D. Sanders,et al.  The role of diet in irritable bowel syndrome: implications for dietary advice , 2019, Journal of internal medicine.

[3]  T. Hausken,et al.  Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS) , 2019, Neuropeptides.

[4]  G. Monteleone,et al.  Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer , 2018, Front. Immunol..

[5]  J. Pêgo,et al.  A Key Role for Neurotensin in Chronic-Stress-Induced Anxiety-Like Behavior in Rats , 2018, Neuropsychopharmacology.

[6]  I. Akirav,et al.  The effects of enhancing endocannabinoid signaling and blocking corticotrophin releasing factor receptor in the amygdala and hippocampus on the consolidation of a stressful event , 2017, European Neuropsychopharmacology.

[7]  Y. Taché,et al.  Peripheral Corticotropin Releasing Factor Signaling Inhibits Gastric Emptying: Mechanisms of Action and Role in Stress-related Gastric Alterations of Motor Function. , 2017, Current pharmaceutical design.

[8]  S. Park,et al.  Corticotropin-releasing factor stimulates colonic motility via muscarinic receptors in the rat , 2017, World journal of gastroenterology.

[9]  H. Kim,et al.  The Effect of Peripheral CRF Peptide and Water Avoidance Stress on Colonic and Gastric Transit in Guinea Pigs , 2017, Yonsei medical journal.

[10]  G. Chao,et al.  Aquaporins 1, 3 and 8 expression in irritable bowel syndrome rats’ colon via NF-κB pathway , 2017, Oncotarget.

[11]  S. Puli,et al.  Irritable Bowel Syndrome: A Clinical Review. , 2016, Current rheumatology reviews.

[12]  S. Yao,et al.  Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target? , 2016, Journal of Zhejiang University-SCIENCE B.

[13]  T. Oshima,et al.  Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World , 2015, Journal of neurogastroenterology and motility.

[14]  Bo Yang,et al.  Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome , 2015, BMC Gastroenterology.

[15]  Jacob E. Kurlander,et al.  Irritable bowel syndrome: a clinical review. , 2015, JAMA.

[16]  C. Croce,et al.  Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1 , 2015, Gut.

[17]  L. Chang,et al.  Cytokine imbalance in irritable bowel syndrome: a systematic review and meta‐analysis , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[18]  Jingguo Gao.  Correlation between anxiety-depression status and cytokines in diarrhea-predominant irritable bowel syndrome , 2013, Experimental and therapeutic medicine.

[19]  S. Lecleire,et al.  Role of Toll Like Receptors in Irritable Bowel Syndrome: Differential Mucosal Immune Activation According to the Disease Subtype , 2012, PloS one.

[20]  A. Ford,et al.  Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  N. Rezaei,et al.  Cytokines and irritable bowel syndrome: where do we stand? , 2012, Cytokine.

[22]  Cheng Lan,et al.  Study on the expression of Runx3 and TGF-β₁ protein in the colonic tissue from rats with irritable bowel syndrome. , 2011, Asian Pacific journal of tropical medicine.

[23]  Ching-Liang Lu,et al.  The Current Prevalence of Irritable Bowel Syndrome in Asia , 2010, Journal of neurogastroenterology and motility.

[24]  L. Öhman,et al.  Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions , 2010, Nature Reviews Gastroenterology &Hepatology.

[25]  A. Kantarcı,et al.  Gingival inflammation and interleukin-1 beta and tumor necrosis factor-alpha levels in gingival crevicular fluid during the menstrual cycle. , 2009, Journal of periodontology.

[26]  K. Labuzek,et al.  Transforming growth factor-beta1 and its receptors in patients with ulcerative colitis. , 2009, International immunopharmacology.

[27]  Y. Taché,et al.  Neuroendocrine control of the gut during stress: corticotropin-releasing factor signaling pathways in the spotlight. , 2009, Annual review of physiology.

[28]  S. Fukudo.  Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation , 2007, Journal of Gastroenterology.

[29]  P. Whorwell,et al.  Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? , 2003, Gut.

[30]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[31]  R. Spiller,et al.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acuteCampylobacter enteritis and in post-dysenteric irritable bowel syndrome , 2000, Gut.